These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7998026)

  • 1. [Somatostatin as a help in fistula problems].
    Guldvog I
    Tidsskr Nor Laegeforen; 1994 Oct; 114(24):2827-8. PubMed ID: 7998026
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-surgical management of a lymphatic fistula, after laparoscopic colorectal surgery, with total parenteral nutrition, octreotide, and somatostatin.
    Giovannini I; Giuliante F; Chiarla C; Ardito F; Vellone M; Nuzzo G
    Nutrition; 2005 Oct; 21(10):1065-7. PubMed ID: 16157245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin analog treatment of a cervical thoracic duct fistula.
    Valentine CN; Barresi R; Prinz RA
    Head Neck; 2002 Aug; 24(8):810-3. PubMed ID: 12203809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of octreotide in the treatment of pancreatic fistula].
    Zelli GP
    Minerva Chir; 1992 Apr; 47(8):735-6. PubMed ID: 1351279
    [No Abstract]   [Full Text] [Related]  

  • 5. [Somatostatin in the treatment of pancreatic diseases].
    Németh AM
    Orv Hetil; 2002 May; 143(19 Suppl):1099-108. PubMed ID: 12063869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial comparing somatostatin with octreotide in the prevention of complications after pancreatectomy.
    Closset J; Journe S; Mboti F; El Nakadi I; Gelin M
    Hepatogastroenterology; 2008; 55(86-87):1818-23. PubMed ID: 19102400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of biliobronchial fistula with octreotide: a case report.
    Petrolati A; Pacella CM; Nasoni S; Rossi Z; Altavilla N; Cipolla R; Fenderico P; Forlini G; Stasi R
    Am J Gastroenterol; 2009 Oct; 104(10):2638-9. PubMed ID: 19806104
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic applications of somatostatin and its analogue octreotide.
    Harris AG; Kokoris SP
    Eur J Med; 1993 Feb; 2(2):97-105. PubMed ID: 7903061
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of somatostatin analog in the management of traumatic parotid fistula.
    Lam CM; Wong SY
    Surgery; 1996 Apr; 119(4):481-2. PubMed ID: 8644019
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of somatostatin and octreotide on experimental and human acute pancreatitis.
    Greenberg R; Haddad R; Kashtan H; Kaplan O
    J Lab Clin Med; 2000 Feb; 135(2):112-21. PubMed ID: 10695655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of somatostatin and its long-acting analogue, octreotide, in the treatment of pancreatic diseases.
    Delmont J; Hastier P; Dumas R
    Aliment Pharmacol Ther; 1995 Oct; 9(5):581-3. PubMed ID: 8580282
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuroendocrine tumors--somatostatin receptor expression and somatostatin analog treatment.
    Janson ET; Oberg K
    Cancer Chemother Biol Response Modif; 2003; 21():535-46. PubMed ID: 15338762
    [No Abstract]   [Full Text] [Related]  

  • 13. [Somatostatin and its analogs in the treatment of gastrointestinal and liver diseases].
    Feu F; Bosch J
    Gastroenterol Hepatol; 1996 Feb; 19(2):68-77. PubMed ID: 8616683
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of chylothorax in a premature infant using somatostatin.
    Goto M; Kawamata K; Kitano M; Watanabe K; Chiba Y
    J Perinatol; 2003 Oct; 23(7):563-4. PubMed ID: 14566354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trial: The effect of somatostatin vs. octreotide in preventing post-endoscopic increase in hepatic venous pressure gradient in cirrhotics with bleeding varices.
    Vlachogiannakos J; Kougioumtzian A; Triantos C; Viazis N; Sgouros S; Manolakopoulos S; Saveriadis A; Markoglou C; Economopoulos T; Karamanolis DG
    Aliment Pharmacol Ther; 2007 Dec; 26(11-12):1479-87. PubMed ID: 17919272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can somatostatin derivatives really be suggested in the treatment of chylothorax?
    Bernet-Buettiker V
    Pediatr Crit Care Med; 2007 May; 8(3):308; author reply 308-9. PubMed ID: 17496524
    [No Abstract]   [Full Text] [Related]  

  • 17. [Management of postoperative pancreatic fistula resistant to octreotide therapy].
    Dobosz M; Dymecki D; Babicki A; Hać S; Gruca Z; Wajda Z
    Wiad Lek; 2001; 54(7-8):380-5. PubMed ID: 11641892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results.
    Poon RT; Fan ST
    JOP; 2003 Jan; 4(1):33-40. PubMed ID: 12555014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of somatostatin analogs in the treatment of neuroendocrine tumours and paraneoplastic syndromes].
    Sperlongano P; De Falco M; Pisaniello D; Parmeggiani D; Parmeggiani U
    Minerva Endocrinol; 2001 Dec; 26(4):293-5. PubMed ID: 11782719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of somatostatin in the management of upper gastrointestinal bleeding].
    Herszényi L
    Orv Hetil; 2002 May; 143(19 Suppl):1092-9. PubMed ID: 12063868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.